Earnings
AOS
63.28
-0.14%
-0.09
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2025
3.83B
3.83B
--
2.34B
1.49B
772.30M
759.40M
--
--
13.50M
0.00
-600.00K
715.10M
--
--
--
715.10M
168.90M
546.20M
--
--
--
546.20M
--
546.20M
--
546.20M
546.20M
--
546.20M
141.91M
3.85
3.85
1.40
3.85
FY 2024
3.82B
3.82B
--
2.36B
1.46B
755.10M
739.30M
--
--
6.70M
17.60M
-8.50M
701.00M
--
--
--
701.00M
167.40M
533.60M
--
--
--
533.60M
--
533.60M
--
533.60M
533.60M
--
533.60M
147.08M
3.63
3.63
1.32
3.72
FY 2023
3.85B
3.85B
--
2.37B
1.48B
751.30M
727.40M
--
--
12.00M
18.80M
-6.90M
733.50M
--
--
--
733.50M
176.90M
556.60M
--
--
--
556.60M
--
556.60M
--
556.60M
556.60M
--
556.60M
151.02M
3.69
3.69
1.24
3.78
FY 2022
3.75B
3.75B
--
2.42B
1.33B
1.11B
670.90M
--
--
9.40M
0.00
425.60M
223.70M
--
--
--
223.70M
-12.00M
235.70M
--
--
--
235.70M
--
235.70M
--
235.70M
235.70M
--
235.70M
155.78M
1.51
1.51
1.44
1.48
FY 2021
3.54B
3.54B
--
2.23B
1.31B
685.30M
701.40M
--
--
4.30M
0.00
-20.40M
625.60M
--
--
--
625.60M
138.50M
487.10M
--
--
--
487.10M
--
487.10M
--
487.10M
487.10M
--
487.10M
161.32M
3.02
3.02
1.06
3.02

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.